ketoconazole has been researched along with Retinal Degeneration in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole is a weakly dibasic synthetic imidazole with a broad spectrum of antifungal activity." | 1.27 | Experimental intravitreal ketoconazole in DMSO. ( Banihashemi, AR; Yoshizumi, MO, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshizumi, MO | 1 |
| Banihashemi, AR | 1 |
1 other study available for ketoconazole and Retinal Degeneration
| Article | Year |
|---|---|
Experimental intravitreal ketoconazole in DMSO.
Topics: Administration, Topical; Animals; Dimethyl Sulfoxide; Electroretinography; Endophthalmitis; Ketocona | 1988 |